These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38563148)

  • 1. Blood Pressure Lowering in Patients With Central Hypertension: A Randomized Clinical Trial.
    Sharman JE; Otahal P; Stowasser M; Stanton T; Reid CM; Nolan M; Roberts-Thomson P; Negishi K; Greenough R; Stewart S; Marwick TH; Abhayaratna WP
    Hypertension; 2024 Jun; 81(6):1400-1409. PubMed ID: 38563148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study).
    Sharman JE; Stanton T; Reid CM; Keech A; Roberts-Thomson P; Stewart S; Greenough R; Stowasser M; Abhayaratna WP
    Contemp Clin Trials; 2017 Nov; 62():37-42. PubMed ID: 28822828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between 24-Hour Ambulatory Central Systolic Blood Pressure and Left Ventricular Mass: A Prospective Multicenter Study.
    Weber T; Wassertheurer S; Schmidt-Trucksäss A; Rodilla E; Ablasser C; Jankowski P; Lorenza Muiesan M; Giannattasio C; Mang C; Wilkinson I; Kellermair J; Hametner B; Pascual JM; Zweiker R; Czarnecka D; Paini A; Salvetti M; Maloberti A; McEniery C
    Hypertension; 2017 Dec; 70(6):1157-1164. PubMed ID: 29061725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation.
    Mancia G; Zanchetti A; Agabiti-Rosei E; Benemio G; De Cesaris R; Fogari R; Pessina A; Porcellati C; Rappelli A; Salvetti A; Trimarco B
    Circulation; 1997 Mar; 95(6):1464-70. PubMed ID: 9118514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
    Nyström F; Malmqvist K; Ohman KP; Kahan T
    J Hypertens; 2002 Aug; 20(8):1527-33. PubMed ID: 12172314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.
    Soliman EZ; Byington RP; Bigger JT; Evans G; Okin PM; Goff DC; Chen H
    Hypertension; 2015 Dec; 66(6):1123-9. PubMed ID: 26459421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study.
    Sharman JE; Marwick TH; Gilroy D; Otahal P; Abhayaratna WP; Stowasser M;
    Hypertension; 2013 Dec; 62(6):1138-45. PubMed ID: 24060891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
    Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of Out-of-Office Blood Pressure for Predicting Hypertensive Heart Disease in Non-Hispanic Black Adults.
    Rader F; Franklin SS; Mirocha J; Vongpatanasin W; Haley RW; Victor RG
    Hypertension; 2019 Nov; 74(5):1192-1199. PubMed ID: 31522619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment).
    Krieger EM; Drager LF; Giorgi DMA; Pereira AC; Barreto-Filho JAS; Nogueira AR; Mill JG; Lotufo PA; Amodeo C; Batista MC; Bodanese LC; Carvalho ACC; Castro I; Chaves H; Costa EAS; Feitosa GS; Franco RJS; Fuchs FD; Guimarães AC; Jardim PC; Machado CA; Magalhães ME; Mion D; Nascimento RM; Nobre F; Nóbrega AC; Ribeiro ALP; Rodrigues-Sobrinho CR; Sanjuliani AF; Teixeira MDCB; Krieger JE;
    Hypertension; 2018 Apr; 71(4):681-690. PubMed ID: 29463627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial.
    Muxfeldt ES; Margallo V; Costa LM; Guimarães G; Cavalcante AH; Azevedo JC; de Souza F; Cardoso CR; Salles GF
    Hypertension; 2015 Apr; 65(4):736-42. PubMed ID: 25601933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction.
    Rossignol P; Claggett BL; Liu J; Vardeny O; Pitt B; Zannad F; Solomon S
    Am J Hypertens; 2018 Mar; 31(4):407-414. PubMed ID: 29228101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Amlodipine/Lisinopril Fixed-Dose Combination on Severity of Left Ventricular Hypertrophy and Parameters of Myocardial Stiffness in Patients With Hypertension].
    Ostroumova OD; Kochetkov AI
    Kardiologiia; 2016 Dec; 56(11):27-37. PubMed ID: 28290816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT).
    Agarwal R
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
    Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
    Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial.
    Hayer MK; Edwards NC; Slinn G; Moody WE; Steeds RP; Ferro CJ; Price AM; Andujar C; Dutton M; Webster R; Webb DJ; Semple S; MacIntyre I; Melville V; Wilkinson IB; Hiemstra TF; Wheeler DC; Herrey A; Grant M; Mehta S; Ives N; Townend JN
    Am Heart J; 2017 Sep; 191():37-46. PubMed ID: 28888268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.
    Václavík J; Sedlák R; Plachy M; Navrátil K; Plásek J; Jarkovsky J; Václavík T; Husár R; Kociánová E; Táborsky M
    Hypertension; 2011 Jun; 57(6):1069-75. PubMed ID: 21536989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
    Sato A; Suzuki Y; Saruta T
    Hypertens Res; 1999 Mar; 22(1):17-22. PubMed ID: 10221346
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.